Metabolomic identification of biochemical changes induced by fluoxetine in an insulinoma cell line (MIN6)

Surachai Ngamratanapaiboon , Krittaboon Pornchokchai, Siriphattarinya Wongpitoonmanachai, Petchlada Pholkla, Napatarin Srikornvit, Jiajun Mo, Patipol Hongthawonsiri, Pracha Yambangyang, Pilaslak Akrachalanont

Abstract


Background and purpose: The use of fluoxetine raises the risk of pancreatic beta-cell dysfunction. However, the specific mechanism behind its mechanism of action in beta cells is unknown. This study investigated the cellular response of MIN6 cells to fluoxetine using untargeted cell-based metabolomics.

Experimental approach: Metabolic profiling of MIN6 cells was performed using liquid chromatography-high resolution mass spectrometry (LC-HRMS) analysis on samples prepared under optimized conditions, followed by principal component analysis, partial least squares-discriminant analysis, and pair-wise orthogonal projections to latent structures discriminant analyses.

Findings/Results: Sixty-six metabolites that had been differentially expressed between the control and fluoxetine-treated groups demonstrated that the citric acid cycle is mainly perturbed by fluoxetine treatment.

Conclusion and implications: The current study provides insights into the molecular mechanisms of fluoxetine effects in MIN6 cells.

Highlights

Surachai Ngamratanapaiboon : PubMed , Google Scholar

 


Keywords


Fluoxetine; High-resolution mass spectrometry; Insulinoma cell line; Liquid chromatography; Metabolomics.

Full Text:

PDF

References


Carratalá-Ros C, López-Cruz L, Martínez-Verdú A, Olivares-García R, Salamone JD, Correa M. Impact of fluoxetine on behavioral invigoration of appetitive and aversively motivated responses: interaction with dopamine depletion. Front Behav Neurosci. 2021;15:700182,1-15. DOI: 10.3389/fnbeh.2021.700182.

Reyad AA, Plaha K, Girgis E, Mishriky R. Fluoxetine in the management of major depressive disorder in children and adolescents: a meta-analysis of randomized controlled trials. Hosp Pharm. 2020;56(5):525-531. DOI: 10.1177/0018578720925384.

Zhao J, Jung YH, Jang CG, Chun KH, Kwon SW, Lee J. Metabolomic identification of biochemical changes induced by fluoxetine and imipramine in a chronic mild stress mouse model of depression. Sci Rep. 2015;5:8890,1-8. DOI: 10.1038/srep08890.

Chang HY, Chen SL, Shen MR, Kung ML, Chuang LM, Chen YW. Selective serotonin reuptake inhibitor, fluoxetine, impairs E-cadherin-mediated cell adhesion and alters calcium homeostasis in pancreatic beta cells. Sci Rep. 2017;7:3515,1-13. DOI: 10.1038/s41598-017-03747-0.

De Long NE, Hyslop JR, Raha S, Hardy DB, Holloway AC. Fluoxetine-induced pancreatic beta cell dysfunction: new insight into the benefits of folic acid in the treatment of depression. J Affect Disord. 2014;166:6-13. DOI: 10.1016/j.jad.2014.04.063.

Elmorsy E, Alelwani W, Kattan S, Babteen N, Alnajeebi A, Ghulam J, et al. Antipsychotics inhibit the mitochondrial bioenergetics of pancreatic beta cells isolated from CD1 mice. Basic Clin Pharmacol Toxicol. 2021;128(1):154-168. DOI: 10.1111/bcpt.13484.

Sagahón-Azúa J, Medellín-Garibay SE, Chávez-Castillo CE, González-Salinas CG, Milán-Segovia RDC, Romano-Moreno S. Factors associated with fluoxetine and norfluoxetine plasma concentrations and clinical response in Mexican patients with mental disorders. Pharmacol Res Perspect. 2021;9(5):e00864,1-10. DOI: 10.1002/prp2.864.

Keyvanloo Shahrestanaki M, Aghaei M. A3 receptor agonist, Cl-IBMECA, potentiate glucose-induced insulin secretion from MIN6 insulinoma cells possibly through transient Ca2+ entry. Res Pharm Sci. 2019;14(2):107-114. DOI: 10.4103/1735-5362.253357.

Elmorsy E, Al-Ghafari A, Almutairi FM, Aggour AM, Carter WG. Antidepressants are cytotoxic to rat primary blood brain barrier endothelial cells at high therapeutic concentrations. Toxicol In Vitro. 2017;44:154-163. DOI: 10.1016/j.tiv.2017.07.011.

Ngamratanapaiboon S, Yambangyang P. Quantification of antipsychotic biotransformation in brain microvascular endothelial cells by using untargeted metabolomics. Drug Discov Ther. 2021;15(6):317-324. DOI: 10.5582/ddt.2021.01101.

Ahangarpour A, Shabani R, Farbood Y. The effect of betulinic acid on leptin, adiponectin, hepatic enzyme levels and lipid profiles in streptozotocin-nicotinamide-induced diabetic mice. Res Pharm Sci. 2018;13(2):142-148. DOI: 10.4103/1735-5362.223796.

Collette TW, Ekman DR, Zhen H, Nguyen H, Bradley PM, Teng Q. Cell-based metabolomics for untargeted screening and prioritization of vertebrate-active stressors in streams across the United States. Environ Sci Technol. 2019;53(15):9232-9240. DOI: 10.1021/acs.est.9b02736.

Wright Muelas M, Roberts I, Mughal F, O'Hagan S, Day PJ, Kell DB. An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines. Metabolomics. 2020;16(10):107,1-12. DOI: 10.1007/s11306-020-01725-8.

Cataldo LR, Cortés VA, Mizgier ML, Aranda E, Mezzano D, Olmos P, et al. Fluoxetine impairs insulin secretion without modifying extracellular serotonin levels in MIN6 β-cells. Exp Clin Endocrinol Diabetes. 2015;123(8):473–478. DOI: 10.1055/s-0035-1549964.

Roopan S, Larsen ER. Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review. Acta Neuropsychiatr. 2017;29(3):127-139. DOI: 10.1017/neu.2016.54.

Biagetti B, Corcoy R. Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes. World J Clin Cases. 2013;1(5):169-171. DOI: 10.12998/wjcc.v1.i5.169.

Jensen MV, Joseph JW, Ronnebaum SM, Burgess SC, Sherry AD, Newgard CB. Metabolic cycling in control of glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab. 2008;295(6):E1287-E1297. DOI: 10.1152/ajpendo.90604.2008.

Maechler P, Wollheim CB. Mitochondrial signals in glucose-stimulated insulin secretion in the beta cell. J Physiol. 2000;529(Pt1):49-56. DOI: 10.1111/j.1469-7793.2000.00049.x.

Tengholm A. Cyclic AMP dynamics in the pancreatic β-cell. Ups J Med Sci. 2012;117(4):355-369. DOI: 10.3109/03009734.2012.724732.

Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A, et al. ATP synthesis and storage. Purinergic Signal. 2012;8(3):343-357. DOI: 10.1007/s11302-012-9305-8.

Kao CY, He Z, Henes K, Asara JM, Webhofer C, Filiou MD, et al. Fluoxetine treatment rescues energy metabolism pathway alterations in a posttraumatic stress disorder mouse model. Mol Neuropsychiatry. 2016;2(1):46-59. DOI: 10.1159/000445377.


Refbacks

  • There are currently no refbacks.


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.